Tocilizumab as an Adjuvant Therapy for Hemophagocytic Lymphohistiocytosis Associated With Visceral Leishmaniasis

Artículo original

Año: 2016

Rios-Fernandez, R; Callejas-Rubio, JL; Garcia-Rodriguez, S; Sancho, J; Zubiaur, M; Ortego-Centeno, N

Título: AMERICAN JOURNAL OF THERAPEUTICS

• Q4